United States · FDA National Drug Code directory
Spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70518-3625_562d084f-fc88-f3f0-e063-6294a90a34ad
- Product NDC
- 70518-3625
- Form
- TABLET, COATED
- Composition / generic term
- Spironolactone
- Labeler
- REMEDYREPACK INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230127
- Source listing expiry
- 20271231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, COATED in 1 BLISTER PACK (70518-3625-0) · 70518-3625-0
- 100 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-3625-1) · 70518-3625-1
- 90 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-3625-2) · 70518-3625-2
- 30 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-3625-3) · 70518-3625-3
- 100 POUCH in 1 BOX (70518-3625-4) / 1 TABLET, COATED in 1 POUCH (70518-3625-5) · 70518-3625-4
- 30 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-3625-6) · 70518-3625-6
- 100 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-3625-7) · 70518-3625-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →